09:48 AM EST - Curaleaf Holdings, Inc. : In collaboration with Jupiter Research LLC, a subsidiary of TILT Holdings Inc., has secured regulatory approval for the first handheld liquid inhalation device designed for precise medical cannabis administration. This EU medical device certification (Regulation (EU) 2017/745) paves the way for improved patient options and a new era of innovation in medical cannabis delivery. Curaleaf Holdings, Inc.
shares T.CURA are trading up $0.06 at $1.20.
